Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorKlinički Bolnički Centar Zagreb

About this trial

Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.

Eligibility criteria

Qualifiers

None

Disqualifiers

Left ventricular ejection fraction <30%

Associated cardiac procedures

Off-pump coronary artery bypass grafting

Contraindications for MRI

Trial design

Treatments tested in this trial

  • Del Nido Cardioplegia Solution for myocardial protection
  • Blood Cardioplegia Solution for myocardial protection

Treatment groups

60 Participants
are divided into 2 treatment groups